Migraine Disorders
215
23
29
128
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
53 trials with published results (25%)
Research Maturity
128 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.6%
12 terminated out of 215 trials
91.4%
+4.9% vs benchmark
28%
61 trials in Phase 3/4
41%
53 of 128 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 128 completed trials
Clinical Trials (215)
Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial
MMA Embolization for Refractory Chronic Migraine
Migraine Attack Pain Phase Prediction Study
Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine
MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine
Mind Body Balance for Pediatric Migraine
Determining the Utility of a Behavioral Intervention in Chronic Migraine
Using Virtual Reality to Teach Mindfulness to People With Migraine
Trigeminal Brainstem Mapping 2: Higher Cortical Strucureas as Well as Subnuclei of the Spinal Trigeminal Nucleus
Greater Occipital Nerve Block for Migraine With Medication Overuse Headache
Migraine Manager (R01)
Responding With Evidence and Access for Childhood Headaches
Videonystagmography and Vestibular Migraine
Fremanezumab, Migraine and Sleep
EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization
Therapy for Migraine Prevention in Children 6-11 Years of Age
Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine
Amylin-Induced Migraine Attacks Without Aura
Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment